Sightline Wealth Advisors »

Global X Fds genomic biotech shares owned by Sightline Wealth Advisors

Quarter-by-quarter ownership of Global X Fds genomic biotech (GNOM) shares owned by Sightline Wealth Advisors from 13F filings

Historical chart of Sightline Wealth Advisors investment in Global X Fds genomic biotech

Tip: Access up to 7 years of quarterly data

All positions including Global X Fds genomic biotech held by Sightline Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Global X Fds genomic biotech by Sightline Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $706k 62k 11.38
2023-12-31 $738k 64k 11.56
2023-09-30 $735k 72k 10.17
2023-06-30 $890k 72k 12.32
2023-03-31 $890k 72k 12.32
2022-12-31 $928k 73k 12.65
2022-09-30 $685k 54k 12.59
2022-06-30 $501k 41k 12.23
2022-03-31 $300k 20k 15.02
2021-12-31 $291k 15k 19.55